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Supplement 
Suppl. Table 1: Causes of cardiovascular death. 
 
n [%] 
Cause of cardiovascular death 
total n = 91 [100] 
cardiac 56 [62] 
STEMI   9 [10] 
NSTEMI 35 [38] 
CABG 12 [13] 
cerebrovascular 35 [38] 
Stroke 25 [28] 
Carotid operation 10 [11] 
STEMI = ST-elevation myocardial infarction; NSTEMI = non-ST elevation myocardial 



















































  PAD 3D Score tp tn fn fp Sensitivity, % Specificity, % Post-test probability, % Pre-test probability, % 
Mortality within 1 
month                 1% 
  1 17 106 0 1187 100 8 1   
  2 17 241 0 1052 100 19 2   
  3 15 406 2 887 88 31 2   
  4 15 597 2 696 88 46 2   
  5 11 775 6 518 65 60 2   
  6 7 969 10 324 41 75 2   
  7 4 1054 13 239 24 82 2   
  8 3 1120 14 173 18 87 2   
  9 2 1222 15 71 12 95 3   
  10 2 1245 15 48 12 96 4   
  ≥11 1 1271 16 22 6 98 4   
                    
                    
Mortality within 6 
months                 4% 
  1 56 106 0 1148 100 8 5   
  2 55 240 1 1014 98 19 5   
  3 48 400 8 854 86 32 5   
  4 44 587 12 667 79 47 6   
  5 39 764 17 490 70 61 7   
  6 29 952 27 302 52 76 9   
  7 23 1034 33 220 41 82 9   
  8 18 1096 38 158 32 87 10   
  9 9 1190 47 64 16 95 12   
  10 6 1210 50 44 11 96 12   
  ≥11 3 1234 53 20 5 98 13   
                    
                    
Mortality within 1 
year                 7% 
  1 92 106 0 1112 100 9 8   
  2 89 238 3 980 97 20 8   
  3 80 396 12 822 87 33 9   
  4 73 580 19 638 79 48 10   
  5 64 753 28 465 70 62 12   
  6 47 934 45 284 51 77 14   
  7 39 1014 53 204 42 83 16   
  8 32 1074 60 144 35 88 18   
  9 18 1163 74 55 20 95 25   
  10 15 1183 77 35 16 97 30   
  ≥11 5 1200 87 18 5 99 22   
                    
                    
Mortality within 18 
months                 10% 
  1 118 97 2 1035 98 9 10   
  2 114 224 6 908 95 20 11   
  3 103 376 17 756 86 33 11   
  4 94 549 26 583 78 48 13   
  5 81 707 39 425 68 62 15   
  6 58 873 62 259 48 77 18   
  7 45 945 75 187 38 83 19   
  8 38 1004 82 128 32 89 22   
  9 18 1081 102 51 15 95 25   
  10 15 1101 105 31 13 97 32   
  ≥11 5 1117 115 15 4 99 24   
                    
                    
Mortality within 2 
years                 12% 
  1 137 87 2 914 99 9 11   
  2 131 203 8 798 94 20 12   
  3 120 333 19 668 86 33 13   
  4 107 483 32 518 77 48 15   
  5 92 622 47 379 66 62 17   
  6 65 771 74 230 47 77 19   
  7 51 836 88 165 37 84 21   
  8 42 885 97 116 30 88 24   
  9 20 955 119 46 14 95 27   
  10 17 975 122 26 12 97 36   
  ≥11 7 990 132 11 5 99 35   
                    
                    
Mortality within 3 
years                 17% 
  1 171 79 2 739 99 10 14   
  2 162 177 11 641 94 22 15   
  3 147 285 26 533 85 35 17   
  4 130 415 43 403 75 51 19   
  5 111 524 62 294 64 64 21   
  6 78 642 95 176 45 78 24   
  7 60 694 113 124 35 85 26   
  8 46 729 127 89 27 89 27   
  9 22 782 151 36 13 96 31   
  10 18 796 155 22 10 97 37   
  ≥11 7 808 166 10 4 99 33   
                    
                    
Mortality within 4 
years                 23% 
  1 199 70 2 605 99 10 17   
  2 189 150 12 525 94 22 18   
  3 170 244 31 431 85 36 19   
  4 147 348 54 327 73 52 21   
  5 124 438 77 237 62 65 24   
  6 86 530 115 145 43 79 27   
  7 66 577 135 98 33 85 29   
  8 50 605 151 70 25 90 30   
  9 24 645 177 30 12 96 33   
  10 19 657 182 18 9 97 39   
  ≥11 8 667 193 8 4 99 38   
                    
                    
Mortality within 5 
years                 30% 
  1 213 53 2 456 99 10 18   
  2 202 118 13 391 94 23 19   
  3 178 187 37 322 83 37 20   
  4 155 263 60 246 72 52 23   
  5 130 327 85 182 60 64 25   
  6 92 403 123 106 43 79 29   
   PAD RF Score tp tn fn fp Sensitivity, % Specificity, % Post-test probability, % Pre-test probability, % 
Mortality within 1 month               1% 
  1 17 30 0 1263 100 2 1   
  2 17 87 0 1206 100 7 1   
  3 17 170 0 1123 100 13 1   
  4 17 292 0 1001 100 23 2   
  5 17 437 0 856 100 34 2   
  6 16 597 1 696 94 46 2   
  7 13 771 4 522 76 60 2   
  8 8 911 9 382 47 70 2   
  9 4 1021 13 272 24 79 1   
  10 3 1104 14 189 18 85 2   
  11 2 1175 15 118 12 91 2   
  12 1 1238 16 55 6 96 2   
  ≥13 1 1262 16 31 6 98 3   
Mortality within 6 months               4% 
  1 56 30 0 1224 100 2 4   
  2 55 86 1 1168 98 7 4   
  3 54 168 2 1086 96 13 5   
  4 52 288 4 966 93 23 5   
  5 50 431 6 823 89 34 6   
  6 45 587 11 667 80 47 6   
  7 38 757 18 497 68 60 7   
  8 31 895 25 359 55 71 8   
  9 23 1001 33 253 41 80 8   
  10 17 1079 39 175 30 86 9   
  11 11 1145 45 109 20 91 9   
  12 3 1201 53 53 5 96 5   
  ≥13 1 1223 55 31 2 98 3   
  7 71 439 144 70 33 86 32   
  8 53 459 162 50 25 90 33   
  9 26 487 189 22 12 96 35   
  10 19 496 196 13 9 97 40   
  ≥11 8 504 207 5 4 99 43   
                    
                    
                    
Mortality within 6 
years                 39% 
  1 226 40 2 317 99 11 19   
  2 215 79 13 278 94 22 20   
  3 189 129 39 228 83 36 21   
  4 165 183 63 174 72 51 24   
  5 138 232 90 125 61 65 27   
  6 99 278 129 79 43 78 29   
  7 77 308 151 49 34 86 34   
  8 59 320 169 37 26 90 34   
  9 27 340 201 17 12 95 34   
  10 19 346 209 11 8 97 36   
  ≥11 8 353 220 4 4 99 40   
                    
                    
Mortality within 1 year               7% 
  1 92 30 0 1188 100 2 7   
  2 91 86 1 1132 99 7 7   
  3 90 168 2 1050 98 14 8   
  4 86 286 6 932 93 23 8   
  5 81 426 11 792 88 35 9   
  6 72 578 20 640 78 47 10   
  7 62 745 30 473 67 61 12   
  8 54 882 38 336 59 72 14   
  9 43 985 49 233 47 81 16   
  10 33 1059 59 159 36 87 17   
  11 23 1121 69 97 25 92 19   
  12 9 1171 83 47 10 96 16   
  ≥13 4 1190 88 28 4 98 13   
Mortality within 18 months               10% 
  1 119 27 1 1105 99 2 9   
  2 118 78 2 1054 98 7 10   
  3 117 157 3 975 98 14 10   
  4 112 269 8 863 93 24 11   
  5 106 405 14 727 88 36 12   
  6 94 548 26 584 78 48 13   
  7 76 699 44 433 63 62 14   
  8 61 822 59 310 51 73 16   
  9 50 921 70 211 42 81 18   
  10 39 987 81 145 33 87 20   
  11 28 1047 92 85 23 92 24   
  12 11 1091 109 41 9 96 20   
  ≥13 4 1107 116 25 3 98 13   
Mortality within 2 years               12% 
  1 138 26 1 975 99 3 11   
  2 137 69 2 932 99 7 11   
  3 136 141 3 860 98 14 12   
  4 130 243 9 758 94 24 13   
  5 123 363 16 638 88 36 14   
  6 110 485 29 516 79 48 15   
  7 89 617 50 384 64 62 17   
  8 70 723 69 278 50 72 18   
  9 56 811 83 190 40 81 20   
  10 44 873 95 128 32 87 23   
  11 31 928 108 73 22 93 27   
  12 12 966 127 35 9 97 23   
  ≥13 4 978 135 23 3 98 13   
Mortality within 3 years               17% 
  1 172 24 1 794 99 3 13   
  2 171 64 2 754 99 8 14   
  3 167 123 6 695 97 15 15   
  4 161 214 12 604 93 26 16   
  5 150 315 23 503 87 39 18   
  6 134 409 39 409 77 50 19   
  7 108 510 65 308 62 62 20   
  8 84 598 89 220 49 73 22   
  9 65 671 108 147 38 82 24   
  10 51 720 122 98 29 88 27   
  11 36 765 137 53 21 94 33   
  12 13 790 160 28 8 97 25   
  ≥13 5 800 168 18 3 98 17   
Mortality within 4 years               23% 
  1 200 21 1 654 100 3 16   
  2 199 57 2 618 99 8 16   
  3 194 104 7 571 97 15 17   
  4 187 182 14 493 93 27 19   
  5 172 259 29 416 86 38 20   
  6 153 343 48 332 76 51 22   
  7 122 425 79 250 61 63 23   
  8 92 495 109 180 46 73 24   
  9 70 560 131 115 35 83 27   
  10 54 597 147 78 27 88 30   
  11 39 635 162 40 19 94 37   
  12 15 656 186 19 7 97 32   
  ≥13 7 663 194 12 3 98 26   
Mortality within 5 years               30% 
  1 214 18 1 491 100 4 17   
  2 212 48 3 461 99 9 18   
  3 206 84 9 425 96 17 18   
  4 197 143 18 366 92 28 20   
  5 181 201 34 308 84 39 21   
  6 161 261 54 248 75 51 23   
  7 130 323 85 186 60 63 25   
  8 98 376 117 133 46 74 26   
  9 75 427 140 82 35 84 30   
  10 57 451 158 58 27 89 31   
  11 41 481 174 28 19 94 40   
  12 16 497 199 12 7 98 38   
  ≥13 8 501 207 8 4 98 32   
                    
Mortality within 6 years               39% 
  1 227 14 1 343 100 4 18   
  2 225 31 3 326 99 9 19   
  3 218 57 10 300 96 16 19   
  4 208 98 20 259 91 27 21   
  5 191 140 37 217 84 39 23   
  6 170 186 58 171 75 52 25   
  7 139 229 89 128 61 64 26   
  8 107 266 121 91 47 75 28   
  9 79 299 149 58 35 84 31   
  10 61 314 167 43 27 88 32   
  11 44 337 184 20 19 94 42   
  12 17 349 211 8 7 98 41   
  13 9 353 219 4 4 99 43   
PAD = peripheral artery disease; PAD3D = peripheral artery disease 3-dimensional risk 





Suppl. Table 2 b 
      Area under ROC curve (95% CI)   
  N 
Number of 
events 
PAD3D PADRF p 
Mortality within 1 month 1310 17 0.669 (0.565 to 0.773) 0.697 (0.621 to 0.772) 0.628 
Mortality within 6 months 1310 56 0.697 (0.629 to 0.764) 0.682 (0.617 to 0.748) 0.525 
Mortality within 1 year 1310 92 0.708 (0.655 to 0.762) 0.702 (0.648 to 0.755) 0.680 
Mortality within 18 months 1252 120 0.692 (0.643 to 0.741) 0.686 (0.639 to 0.734) 0.674 
Mortality within 2 years 1140 139 0.684 (0.638 to 0.730) 0.686 (0.642 to 0.731) 0.876 
Mortality within 3 years 991 173 0.683 (0.640 to 0.725) 0.683 (0.641 to 0.724) 0.998 
Mortality within 4 years 876 201 0.677 (0.636 to 0.717) 0.676 (0.636 to 0.716) 0.953 
Mortality within 5 years 724 215 0.674 (0.632 to 0.716) 0.676 (0.635 to 0.717) 0.878 
Mortality within 6 years 585 228 0.673 (0.629 to 0.717) 0.678 (0.634 to 0.721) 0.702 
 
AUROCs = Area under receiver operating characteristic curves; PAD = peripheral artery 
disease; PAD3D = peripheral artery disease 3-dimensional risk score; PADRF = classical 
PAD risk factors; 
 
Suppl. Figure 1. Age as a predictor of outcome. Kaplan-Meier curves of (A) all-cause 
mortality and (B) cardiovascular mortality over a 72-month-follow-up period in the Test 
cohort.  
Suppl. Figure 2. Severity of the disease i.e. Rutherford stage as a predictor of 
outcome. Kaplan-Meier curves of (A) all-cause mortality and (B) cardiovascular mortality 
over a 72-month-follow-up period in the Test cohort.  
Suppl. Figure 3. Extent of the disease as a predictor of outcome. Kaplan-Meier 
curves of (A) all-cause mortality and (B) cardiovascular mortality over a 72-month-follow-
up period in the Test cohort.  
Suppl. Figure 4. Gender as a predictor of outcome. Kaplan-Meier curves of (A) all-
cause mortality and (B) cardiovascular mortality over a 72-month-follow-up period in the 
Test cohort.  
Suppl. Figure 5. Hypertension as a predictor of outcome. Kaplan-Meier curves of (A) 
all-cause mortality and (B) cardiovascular mortality over a 72-month-follow-up period in 
the Test cohort.  
Suppl. Figure 6. Diabetes mellitus as a predictor of outcome. Kaplan-Meier curves of 
(A) all-cause mortality and (B) cardiovascular mortality over a 72-month-follow-up period 
in the Test cohort.  
Suppl. Figure 7. Smoking status as a predictor of outcome. Kaplan-Meier curves of 
(A) all-cause mortality and (B) cardiovascular mortality over a 72-month-follow-up period 
in the Test cohort.  
Suppl. Figure 8. Dyslipidemia as a predictor of outcome. Kaplan-Meier curves of (A) 
all-cause mortality and (B) cardiovascular mortality over a 72-month-follow-up period in 
the Test cohort.  
Suppl. Figure 9. Combined effects of age, PAD severity and atherosclerotic extent. 
Survival outcomes for (A) all-cause mortality and (B) cardiovascular mortality in patients 
graded along different PAD3D scores, as well as for different PADRF scores (C and D) in 
the Test cohort. 
PAD = peripheral artery disease; PAD3D = peripheral artery disease 3-dimensional risk 
score; PADRF = classical PAD risk factors; 
 
Suppl. Figure 10.  
AUROC between PAD3D and PADRF at (A) 1 month, (B) 6 months, (C) 18 months, (D) 3 
years, (E) 4 years, (F) 5 years and (G) 6 years. 
AUROCs = Area under receiver operating characteristic curves; PAD = peripheral artery 
disease; PAD3D = peripheral artery disease 3-dimensional risk score; PADRF = classical 
PAD risk factors; 
 





